Abel Hall »

Compass Therapeutics shares owned by Abel Hall

Quarter-by-quarter ownership of Compass Therapeutics (CMPX) shares owned by Abel Hall from 13F filings

Historical chart of Abel Hall investment in Compass Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Compass Therapeutics held by Abel Hall consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Compass Therapeutics by Abel Hall

Quarter filed Position value Share count Share price at filing
2025-12-31 $123k 23k 5.37

More positions owned by Abel Hall

Dimensional Etf Trust Us Core Equity 2 (DFAC)
NVIDIA Corporation (NVDA)
Dimensional Etf Trust Intl Core Equity (DFIC)
Dimensional Etf Trust Us High Profitab (DUHP)
Dimensional Etf Trust Us Small Cap Val (DFSV)
Microsoft Corporation (MSFT)
Apple (AAPL)
Dimensional Etf Trust Us Core Eqt Mkt (DFAU)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Dimensional Etf Trust Intl Small Cap V (DISV)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Abel Hall

Top funds holding Compass Therapeutics

Tang Capital Management
OrbiMed Advisors
Suvretta Capital Management
Blackstone Group
Vivo Capital
BlackRock
Vanguard Group
Enavate Sciences GP
Adage Capital Partners GP
State Street Corporation
BVF
FMR
Rock Springs Capital Management
Deerfield Management Company
Geode Capital Management

View all funds holding Compass Therapeutics